Data‐driven analysis was applied on demographic data, apolipoprotein E (APOE) ε4 allele, and 82 biomarkers obtained from blood tests of healthy controls (HC), mild cognitive impairment that remained stable within 36 months following blood collection (sMCI), and patients with AD. The gene discussed is APOE; the disease is Cognitive impairment.